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SUMMARY
Background:  Crude aqueous extract of Zanthoxylum 
xanthozyloides is used locally to treat inflammatory 
conditions.  Previous study confirmed that the extract 
has anti-inflammatory activity and also reduced vascu-
lar response in inflammation.  
Objective:  To identify the effect of the extract on mi-
gration of white blood cells to the site of inflammation.
Method:  The extract was obtained by Soxhlet extrac-
tion and rotatory evaporation, followed by freeze-
drying.  Cohorts of Wistar rats (150g – 200g) were 
randomly assigned to 6 treatment cells, and were given, 
per os, three different treatments:  indomethacin 
(20mg/kg and 40mg/kg), the extract (2000mg/kg and 
4000mg/kg), and 0.9% saline (two groups of control). 
Inflammation was induced with carrageenin in the hind 
paw of the treated groups of rats and one group of the 
control (positive control), one hour after treatment.  
Inflammatory exudates from the inflamed paws were 
collected and the white blood cells (WBCs) counted.
Results:  Carrageenin increased the total WBC count 
(in the paw fluid) which was reduced by the extract and 
indomethacin (p<0.05).  Neither the extract nor indo-
methacin had any effect on total WBC count in the 
non-carrageenin treated control rats.  
Conclusion:  The extract did not affect the pre-existing 
WBC population at the site of inflammation but rather 
inhibited migration of the cells to the site.
Keywords: Root bark extract, Zanthoxylum xanthoxy-
loides, inflammation, migration, white blood cells
INTRODUCTION
Crude aqueous extract of the root bark of Z. xanthoxy-
loides is used widely in Ghana and Nigeria for treating 
various inflammatory conditions.1 Previous study on 
carrageenin-induced inflammation of the rat paw estab-
lished the anti-inflammatory activity of the extract.2
As an anti-inflammatory agent, the extract has been 
found to reduce vascular response in inflammation.3
Since it is common for non-steroidal anti-inflammatory 
drugs (NSAIDs) to interrupt the inflammatory process 
at more than one step4, it became necessary to explore 
further the mechanism(s) underlying the anti-
inflammatory activity of the extract.  
A plausible mechanism, aside modification of the vas-
cular response, is modulation of recruitment of in-
flammatory cells at the site of inflammation.  A drug 
that interrupts the inflammatory process at this level 
(recruitment) would be expected to reduce WBC count 
in inflammatory exudates.  The study was undertaken 
to identify the effect of the extract on WBC count in
inflammatory exudates and, by inference, the migration 
of WBCs to the site of inflammation.
MATERIALS AND METHODS
Collection and extraction of the root bark
The roots of Z. xanthoxyloides (identified and con-
firmed in the Department of Botany, University of 
Ghana, Legon) were collected from a forest at Aka-
tsi,Volta Region, in the month of August and solar-
dried for one day. The root barks were removed, 
washed, and dried in hot oven (55OC) for five days. 
The dried root barks were pulverized to powder. Ali-
quot of the powder, 300g, was extracted in water, 3L, 
in Soxhlet apparatus.6
The extraction was allowed to continue until a point 
where no more brown colouration was imparted to the 
water. This was used as an index for completion of 
extraction. The clear brown extract was concentrated 
10-fold in a rotatory evaporator (Bibby Sterilin rotatory 
evaporator RE - 100). The viscous brown fluid was 
freeze-dried in Edward Modulyo freeze-drier (Edwards 
High Vacuum). The freeze-dried powder was stored at 
–18oC until when needed. Reconstituted freeze-dried 
powder in 0.9% saline is referred to as “the extract” in 
this text. 
Collection of paw fluid from treated rats
Thirty Wistar rats (150g- 200g) of both sexes were 
randomly assigned to 6 groups of 5 rats each (cohort).
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The rats received, per os, three different treatments: 
two groups were given normal saline (control); another 
two groups received two dose levels of indomethacin, 
20 mg/kg and 40 mg/kg respectively; and the remain-
ing two groups, two dose levels of the extract 2000 
mg/kg and 4000 mg/kg respectively. One hour after 
treatment, inflammation was induced by injecting 1% 
(w/v) carrageenin in normal saline, 0.1 ml, into the 
subplantar surface of the hind paw of one group of the 
control and the treated groups of rats. The carrageenin 
treated control rats served as positive control. Three 
hours after the administration of the inflammatory 
agent, the plantar aponeurosis of the inflamed paw was 
inuncted with 2% xylocaine, incised, and the paw fluid 
of each rat aspirated (using 26G hypodermic needle) 
and slowly squirted into a test tube. The residual fluid 
was gently squeezed out, ensuring that blood did not 
mix with the fluid.  Any fluid that had blood in it was 
discarded.  The fluid was examined under microscope 
(x40) for any sign of breakages of the blood cells.
Total WBC count in paw fluid
The paw fluid, 0.02 ml, was mixed with WBC fluid 
(3% acetic acid with crystal violet dye), 0.38 ml, in a 
test tube. The mixture was transferred into a counting 
chamber, and the total number of WBC counted under 
a microscope (x40). The total number of WBCs 
counted was calculated, using the formula: 
WBCs = number of cells counted x depth factor (10) x 
dilution factor (20) x area factor (0.25).
Statistical analysis
Analysis of variance was used to compare the means of 
WBC count of the different treatment groups. Post hoc 
analysis (after-test ANOVA) was employed to compare 
the means of paired observations (inter-groups and 




Carrageenin treatment significantly increased WBC 
population in the inflammatory exudates as indicated 
by higher WBC count in control group 2 than control 
group 1 (Table 1). The total WBC count of control 
group 2 was significantly reduced (p<0.05) by indo-
methacin at both dose levels, 20 mg/kg and 40 mg/kg, 
just as did the extract at both dose levels, 2000mg/kg 
and 4000 mg/kg.  Low dose extract (2000mg/kg) 
caused 16% reduction in the WBC count while high 
dose extract (4000mg/kg) reduced the count by 26%. In 
the case of indomethacin, the low dose (20mg/kg) 
caused 36% reduction in the WBC count and the high 
dose (40mg/kg), 47% reduction.
Table 1:  Effect of the extract and indomethacin on the 
WBC count (x103/ml) in the paw fluid of non-
carrgeenin treated (Control 1) and carrageenin-treated 
(Control 2) rats. 
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Table 2: Paired observations (inter-groups and intra-
groups) in groups of carrageenin-treated rats given 
different dose levels of the extract and indomethacin. 
                               Paired Observation
                                   (mean ± SEM) p-value
0.9% Saline                  : Extract 2000mg/kg
  (2.66 ± 0.12)                    (2.23 ± 0.42)
   0.0825
0.9% Saline                  :  Extract 4000mg/kg
  (2.66 ± 0.12)                    (1.96 ± 0.20)
   0.0001
0.9% Saline                  :  Indomethacin 20mg/kg
  (2.66 ± 0.12)                    (1.71 ± 0.13)
< 0.0001
0.9% Saline                  :  Indomethacin 40mg/kg
  (2.66 ± 0.12)                    (1.41 ± 0.18)
< 0.0001
Extract 2000mg/kg       :  Extract 4000mg/kg
  (2.23 ± 0.42)                    (1.96 ± 0.20)
   0.0357
Extract 2000mg/kg       :  Indomethacin 
20mg/kg
  (2.23 ± 0.42)                    (1.71 ± 0.13)  
   0.0080
Extract 2000mg/kg       :  Indomethacin 
40mg/kg
  (2.23 ± 0.42)                    (1.41 ± 0.18)
   0.0012
Extract 4000mg/kg       :  Indomethacin 
20mg/kg
  (1.96 ± 0.20)                    (1.71 ± 0.13)
   0.1739
Extract 4000mg/kg       :  Indomethacin 
40mg/kg
  (1.96 ± 0.20)                    (1.41 ± 0.18)
   0.0059
Indomethacin 20mg/kg : Indomethacin 40mg/kg
  (1.71 ± 0.13)                    (1.41 ± 0.18) 
   0.0312
Post-hoc analysis showed that the extract or indo-
methacin caused significant (p<0.05) dose-dependent 
percentage reduction in paw fluid WBC count of carra-
geenin-treated rats (Table 2). The percentage reduction 
also differed significantly (p<0.05) among the groups 
of rats receiving different dose levels of the extract and 
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indomethacin. However, there was no significant dif-
ference (p = 0.1739) between the percentage reduction 
in the WBC count caused by 4000mg/kg extract and 
20mg/kg indomethacin.  Even though low dose extract 
(2000mg/kg) caused 16% reduction in WBC count, the 
effect was not significant (p = 0.0825).
Compared to the extract, indomethacin caused a sig-
nificantly greater percentage reduction (p<0.05) in total 
WBC count at the two dose levels.  However, neither 
indomethacin nor the extract treatment had any signifi-
cant effect (p>0.05) on the total WBC count in control 
group 1 (Table 1).  
DISCUSSION
The carrageenin-induced increase in total WBC count 
in the inflammatory exudates of the rat paw is consis-
tent with the fact that increase in WBC population oc-
curs at the site of inflammation.  The increase in the 
total WBC count could mean either there was migra-
tion of WBCs to the site or increase in the population 
of the white cells pre-existing at the site of inflamma-
tion. Significantly, neither the extract nor indomethacin 
had any effect on the total WBC count in control group 
1 (Table 1), suggesting neither the extract nor indo-
methacin had any effect on the population of the WBCs
present at the site prior to the inflammation. The de-
crease in the WBC count caused by the extract and 
indomethacin suggests that the two agents inhibited 
migration of WBCs to the site of inflammation.
It is established that migration of inflammatory cells is 
effected by cell adhesion molecules6 and chemical me-
diators.7,8,9  NSAIDs inhibit migration of inflammatory 
cells by:  inhibiting the release of chemical media-
tors10,11,12; inhibiting the expression of cell adhesion 
molecules 13,14; and inhibiting cell motility.15  Indo-
methacin exhibits all these three mechanisms. Consid-
ering the similarities between the effects of the extract 
and indomethacin, a prototype of NSAIDs, it is possi-
ble that the extract inhibited migration of the WBCs by 
one or more of the aforementioned mechanisms.
CONCLUSION
The results showed that inflammation induced in rats 
by carrageenin is associated with increased WBC count 
at the site of inflammation.  Although the extract did 
not affect the pre-existing WBC population at the site 
of inflammation, it did inhibit migration of the inflam-
matory cells to the site.  This can contribute to the anti-
inflammatory activity of the extract.
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